NCT00411866View on ClinicalTrials.gov

Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 13, 2006

Primary Completion Date

October 10, 2007

Study Completion Date

October 10, 2007

Conditions
Schizophrenia
Interventions
DRUG

SB773812

SB-773812 20 mg will be available as white round film coated tablets.

DRUG

Ketoconazole

Ketoconazole will be available as 200mg tablets.

Trial Locations (1)

DD1 9SY

GSK Investigational Site, Dundee

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00411866 - Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812 | Biotech Hunter | Biotech Hunter